Event-Driven Stocks

IRONWOOD PHARMACEUTICALS INC

IRWDNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 2 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$41.1M$74.9M$104.1M$410.6M$413.8M$389.5M
Operating income$98.5M$93.1M−$945.4M$250.3M$232.3M$142.9M
Net income−$37.4M$880,000$45.7M$175.1M$528.4M$106.2M
Total assets$396.9M$350.9M$471.1M$1.10B$1.13B$559.2M
Total liabilities——————
Equity−$261.8M−$301.3M−$346.3M$652.4M$605.9M$62.6M
EPS (diluted)$-0.23$-0.03$0.25$0.96$3.21$0.66
Shares out.161.8M156.5M154.2M159.2M161.0M158.2M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
239.4%
Net margin
−90.9%
Return on equity
14.3%
Return on assets
−9.4%
Return on capital (ROCE)
63.7%
Liabilities / assets
—
Debt / equity
—
Book value / share
$-1.62
Revenue growth (YoY)
−45.1%
Net income growth (YoY)
−4348.4%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
−41.4%clean
Piotroski F-Score
3/8weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 60Growth 0Catalyst 67Earnings quality 100Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 2 warning● 3 good
  • Negative shareholder equity
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Reported a net loss
  • Revenue declined year-over-year
  • Operating margin is positive
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202617.3M5.8+0.4%
Apr 30, 202617.3M10.5-5.1%
Apr 15, 202618.2M10.2+1.6%
Mar 31, 202617.9M4.7+30.7%
Mar 13, 202613.7M6.7+6.1%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.